VC Fund Dossiers

Blue Lake Capital is the poster child for disciplined, research-driven China investing — which sounds great until you realize they're basically academic VCs who've gotten very lucky with timing. With 2 unicorns (Momenta, Meicai) and 2 IPOs (Jushuitan at $1.68B, Shanghai Hande at $404M), their track record looks solid, but founders should know they're dealing with methodical, process-heavy investors who love their spreadsheets more than gut instincts. Ray Hu's BCG background shows — expect lengthy due diligence, detailed market analysis, and partners who want to see every metric before they move. They're big on post-investment "empowerment" which translates to lots of check-ins about cashflow breakeven and business metrics. The upside? They genuinely understand enterprise software and manufacturing, stick with companies through multiple rounds, and have the patience for long development cycles that B2B businesses need.

CE Ventures is essentially a China-market access fund masquerading as a traditional VC. They help companies enter and accelerate in the Chinese market, find strategic investors in China, and manage relations there - Corephotonics insisted Kan sit on their board despite CreditEase only holding 1% because of his China market contribution. They perform 22 percentage points less than average on lead investments but commit exit 21 percentage points more often than other VCs. The real value prop isn't their capital - it's their CreditEase parent company's massive Chinese network. If you don't need China market entry, you're probably talking to the wrong fund. Fair warning: if your startup has 5+ founders, chances of getting funded are low.